Ignite Creation Date:
2025-12-24 @ 4:50 PM
Ignite Modification Date:
2026-03-15 @ 11:38 AM
Study NCT ID:
NCT03198650
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-10-09
First Post:
2017-06-14
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase 1 Study of Acalabrutinib in Japanese Adult Patients With Advanced B-cell Malignancies
Sponsor:
AstraZeneca
Organization: